BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25412233)

  • 21. An ATRActive future for differentiation therapy in AML.
    Johnson DE; Redner RL
    Blood Rev; 2015 Jul; 29(4):263-8. PubMed ID: 25631637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. All-trans retinoic acid and hematopoietic growth factors regulating the growth and differentiation of blast progenitors in acute promyelocytic leukemia.
    Miyauchi J
    Leuk Lymphoma; 1999 Apr; 33(3-4):267-80. PubMed ID: 10221506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience.
    Cheng Y; Zhang L; Wu J; Lu A; Wang B; Liu G
    Eur J Haematol; 2013 Dec; 91(6):483-9. PubMed ID: 24033687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4-oxo retinoic acid for refractory acute promyelocytic leukemia in children with all-trans retinoic acid therapy.
    Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
    J Nutr Sci Vitaminol (Tokyo); 1995 Aug; 41(4):493-8. PubMed ID: 8676222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16.
    Dembitz V; Lalic H; Tomic B; Smoljo T; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
    Int J Hematol; 2022 Jan; 115(1):43-53. PubMed ID: 34546543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
    Lo-Coco F; Avvisati G; Vignetti M; Thiede C; Orlando SM; Iacobelli S; Ferrara F; Fazi P; Cicconi L; Di Bona E; Specchia G; Sica S; Divona M; Levis A; Fiedler W; Cerqui E; Breccia M; Fioritoni G; Salih HR; Cazzola M; Melillo L; Carella AM; Brandts CH; Morra E; von Lilienfeld-Toal M; Hertenstein B; Wattad M; Lübbert M; Hänel M; Schmitz N; Link H; Kropp MG; Rambaldi A; La Nasa G; Luppi M; Ciceri F; Finizio O; Venditti A; Fabbiano F; Döhner K; Sauer M; Ganser A; Amadori S; Mandelli F; Döhner H; Ehninger G; Schlenk RF; Platzbecker U; ; ;
    N Engl J Med; 2013 Jul; 369(2):111-21. PubMed ID: 23841729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of all-trans-retinoic acid (ATRA) and its analogues: Structures, activities, and mechanisms in acute promyelocytic leukaemia.
    Liang C; Qiao G; Liu Y; Tian L; Hui N; Li J; Ma Y; Li H; Zhao Q; Cao W; Liu H; Ren X
    Eur J Med Chem; 2021 Aug; 220():113451. PubMed ID: 33895500
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Nguyen CH; Grandits AM; Purton LE; Sill H; Wieser R
    Cell Cycle; 2020 Oct; 19(20):2573-2588. PubMed ID: 32900260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation therapy for acute promyelocytic leukemia with all-trans retinoic acid: 10-year experience of its clinical application.
    Wang Z; Sun G; Shen Z; Chen S; Chen Z
    Chin Med J (Engl); 1999 Nov; 112(11):963-7. PubMed ID: 11721474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
    Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
    Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
    Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
    Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia.
    Dubois C; Schlageter MH; de Gentile A; Balitrand N; Toubert ME; Krawice I; Fenaux P; Castaigne S; Najean Y; Degos L
    Leukemia; 1994 Oct; 8(10):1750-7. PubMed ID: 7523800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute promyelocytic leukemia: where did we start, where are we now, and the future.
    Coombs CC; Tavakkoli M; Tallman MS
    Blood Cancer J; 2015 Apr; 5(4):e304. PubMed ID: 25885425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the All-trans-Retinoic Acid and Arsenic Trioxide Combination Treatment for Acute Promyelocytic Leukemia: A Meta-Analysis.
    Ma H; Yang J
    Acta Haematol; 2015; 134(2):101-8. PubMed ID: 25925330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-talk between retinoic acid and interferons: molecular mechanisms of interaction in acute promyelocytic leukemia cells.
    Garattini E; Mologni L; Ponzanelli I; Terao M
    Leuk Lymphoma; 1998 Aug; 30(5-6):467-75. PubMed ID: 9711909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.
    Ozpolat B; Mehta K; Tari AM; Lopez-Berestein G
    Am J Hematol; 2002 May; 70(1):39-47. PubMed ID: 11994980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.
    Masetti R; Biagi C; Zama D; Vendemini F; Martoni A; Morello W; Gasperini P; Pession A
    Adv Ther; 2012 Sep; 29(9):747-62. PubMed ID: 22941525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.
    Kahl M; Brioli A; Bens M; Perner F; Kresinsky A; Schnetzke U; Hinze A; Sbirkov Y; Stengel S; Simonetti G; Martinelli G; Petrie K; Zelent A; Böhmer FD; Groth M; Ernst T; Heidel FH; Scholl S; Hochhaus A; Schenk T
    Leukemia; 2019 Nov; 33(11):2628-2639. PubMed ID: 31576004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.